Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK
Open Access
- 19 April 2016
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 13 (1) , 1-11
Abstract
Glial activation and neuroinflammation in the spinal trigeminal nucleus (STN) play a pivotal role in the genesis and maintenance of trigeminal neuralgia (TN). Resveratrol, a natural compound from grape and red wine, has a potential anti-inflammatory effect. We hypothesized that resveratrol could significantly suppress neuroinflammation in the STN mediated by glial activation and further relieve TN. In this study, we evaluated whether resveratrol could alleviate trigeminal allodynia and explore the mechanism underlying the antinociceptive effect of resveratrol. Animals were orally injected with resveratrol after chronic constriction injury (CCI) of the infraorbital nerve. Mechanical thresholds of the affected whisker pad were measured to assess nociceptive behaviors. The STN was harvested to quantify the changing levels of p-NR1, p-PKC, TNF-α, and IL1-β by western blotting and detect the expression of calcitonin gene-related peptide (CGRP) and c-Fos by immunofluorescence. Glial activation was observed by immunofluorescence and western blotting. Mitogen-activated protein kinase (MAPK) phosphorylation in vivo and in vitro was examined by western blotting. We found that resveratrol significantly attenuated trigeminal allodynia dose-dependently and decreased the increased expression of CGRP and c-Fos in the STN. Additionally, resveratrol showed an inhibitory effect on CCI-evoked astrocyte and microglia activation and reduced production of pro-inflammatory cytokines in the STN. Furthermore, the antinociceptive effect of resveratrol was partially mediated by reduced phosphorylation of MAP kinases via adenosine monophosphate-activated protein kinase (AMPK) activation. AMPK activation in the STN glia via resveratrol has utility in the treatment of CCI-induced neuroinflammation and further implicates AMPK as a novel target for the attenuation of trigeminal neuralgia.Keywords
Funding Information
- Natural Science Foundation of China (81300899, 81202513)
- Foundation of Nanjing Medical University (2014NJMUZD015)
This publication has 58 references indexed in Scilit:
- Reviewing the Role of Resveratrol as a Natural Modulator of Microglial ActivitiesCurrent Pharmaceutical Design, 2015
- Activation of Adenosine Monophosphate–activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer PainAnesthesiology, 2015
- Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s diseaseJournal of Neuroinflammation, 2012
- Nociceptors Are Interleukin-1β SensorsThe Journal of Neuroscience, 2008
- Local Translation in Primary Afferent Fibers Regulates NociceptionPLOS ONE, 2008
- Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein KinasesScience, 2002
- Microglia as a source and target of cytokinesGlia, 2002
- Spinal cord glia: new players in painPain, 2001
- Pro- and Anti-inflammatory Cytokine Gene Expression in Rat Sciatic Nerve Chronic Constriction Injury Model of Neuropathic PainExperimental Neurology, 2001
- Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerveJournal of Neuroscience, 1994